Comparison of the Effect of Hydrophobic Acrylic and Silicone 3-piece IOLs on Posterior Capsule Opacification

Sponsor
Medical University of Vienna (Other)
Overall Status
Completed
CT.gov ID
NCT01936701
Collaborator
(none)
50
1
2
5
9.9

Study Details

Study Description

Brief Summary

Age-related cataract is the main cause of impaired vision in the elderly population worldwide.

The only treatment that can restore functional visual ability is cataract surgery where the opacified crystalline lens is removed by phacoemulsification and an artificial intraocular lens is implanted into the remaining capsular bag. Cataract operations are generally very successful, with a low risk of serious complications.

The most common reason for impaired vision after uneventful cataract surgery in otherwise healthy eyes is the development of posterior capsule opacification (PCO). PCO is a physiological change (thickening, opacification and clouding) of the capsular bag expected after cataract surgery, because the lens epithelial cells (LECs) undergo hyperplasia and cellular migration. PCO is treated with Nd:YAG capsulotomy, a quick outpatient procedure that uses a laser to open a central hole in the posterior capsular bag.

Modifications in IOL design and material lead to a decrease in the incidence of PCO.

During the past two decades, refinements in surgical technique were made resulting in today's small incision phacoemulsification surgery. Nowadays a multitude of microincision IOLs are available, many of them similar but of course with some differences in regard to the chemical composition of the acrylic material and the IOL design.

The purpose of this study is to compare the development of posterior capsule opacification (PCO) and the frequency of treatment between two different microincision IOLs over a period of 2 years.

Condition or Disease Intervention/Treatment Phase
  • Procedure: bilateral cataract surgery
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Official Title:
Comparison of the Effect of Hydrophobic Acrylic and Silicone 3-piece IOLs on Posterior Capsule Opacification
Study Start Date :
Mar 1, 2011
Actual Primary Completion Date :
Mar 1, 2011
Actual Study Completion Date :
Aug 1, 2011

Arms and Interventions

Arm Intervention/Treatment
Other: acrylic 3-piece IOL

same-day bilateral cataract surgery with implantation of intraocular lens Domilens KS-XS in one eye

Procedure: bilateral cataract surgery
same-day bilateral cataract surgery with implantation of intraocular lens

Other: silicone 3-piece IOL

same-day bilateral cataract surgery with implantation of intraocular lens Domilens KS-3Ai in one eye

Procedure: bilateral cataract surgery
same-day bilateral cataract surgery with implantation of intraocular lens

Outcome Measures

Primary Outcome Measures

  1. posterior capsular opacification (PCO) [2 xears]

    subjective and objective PCO scoring

Secondary Outcome Measures

  1. best corrected visual acuity (BCVA) [2 years]

  2. Nd:YAG rate [2 years]

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • bilateral age-related cataract

  • good overall physical constitution

Exclusion Criteria:
  • previous intraocular surgery or ocular trauma

  • intraocular complication like posterior capsular tear

  • glaucoma

  • uveitis

  • corneal diseases, diabetic retinopathy and any other severe retinal -pathology that would make a postoperative visual acuity of 20/40 (decimal equivalent = 0.5) or better unlikely

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Ophthalmology and Optometry of the Medical University Vienna Vienna Austria 1090

Sponsors and Collaborators

  • Medical University of Vienna

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Rupert Menapace, Ao.Univ.-Prof. Dr.med.univ., Medical University of Vienna
ClinicalTrials.gov Identifier:
NCT01936701
Other Study ID Numbers:
  • EK Nr: 112/2011
First Posted:
Sep 6, 2013
Last Update Posted:
Sep 6, 2013
Last Verified:
Sep 1, 2013
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 6, 2013